Thromb Haemost 1993; 69(05): 481-484
DOI: 10.1055/s-0038-1651637
Original Article
Molecular Biology
Schattauer GmbH Stuttgart

A Novel Polymorphism in Glycoprotein IV (Replacement of Proline-90 by Serine) Predominates in Subjects with Platelet GPIV Deficiency

Hirokazu Kashiwagi
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Shigenori Honda
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Yoshiaki Tomiyama
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Hajime Mizutani
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Hironori Take
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Yumiko Honda
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Satoru Kosugi
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Yoshio Kanayama
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
,
Yoshiyuki Kurata
1   Department of Blood Transfusion, Osaka University Hospital, Osaka, Japan
,
Yuji Matsuzawa
The Second Department of Internal Medicine, Osaka University Medical School, Osaka, Japan
› Author Affiliations
Further Information

Publication History

Received 08 July 1992

Accepted after revision 14 January 1993

Publication Date:
25 July 2018 (online)

Preview

Summary

To clarify the molecular basis of the deficiency of glycoprotein IV (GPIV) of the platelet surface, we analyzed GPIV cDNA synthesized from platelet RNA of five unrelated Japanese subjects whose platelets did not express GPIV.

We confirmed the presence of normal-sized GPIV mRNA in platelets from subjects with GPIV deficiency. The sequence of platelet GPIV cDNA from GPIV deficient subject showed three differences when compared with the published sequence; 1) a replacement of a 478CCT codon for proline-90 by TCT for serine, 2) a four-base insertion in the 3′-noncoding region, and 3) a substitution of A for 79C in the 5′-noncoding region. The replacement of Pro90 by Ser predominates in subjects with GPIV deficiency; that is, four out of five platelets with GPIV deficiency contained GPIV mRNA encoding GPIVSer-90, while all platelets from 17 GPIV positive subjects had GPIV mRNA encoding GPIVPro-90. The sequence of platelet GPIV cDNA which did not encode GPIVSer-90 from a subject with GPIV deficiency revealed no abnormality in the coding region. The four-base insertion in the 3′-noncoding region and the substitution of A for 79C in the 5′-noncoding region seems to be unrelated to the expression of GPIV.

The substitution of Ser for Pro90 might alter the GPIV structure or impair GPIV biosynthesis, resulting in a lack of detectable GPIV. This hypothesis remains to be tested.